B. Riley Cuts Geron (NASDAQ:GERN) Price Target to $3.50
Geron (NASDAQ:GERN – Get Free Report) had its target price cut by equities research analysts at B. Riley from $5.50 to $3.50 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. B. Riley’s target price would suggest a potential upside of 37.80% from […]
Geron (NASDAQ:GERN – Get Free Report) had its target price cut by equities research analysts at B. Riley from $5.50 to $3.50 in a note issued to investors on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the biopharmaceutical company’s stock. B. Riley’s target price would suggest a potential upside of 37.80% from […]
